SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-18-001166
Filing Date
2018-01-26
Accepted
2018-01-26 06:01:01
Documents
2
Period of Report
2018-01-22
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tlcc20180125b_8k.htm 8-K 27697
2 EXHIBIT 99.1 ex_103646.htm EX-99.1 6758
  Complete submission text file 0001437749-18-001166.txt   35862
Mailing Address 632 BROADWAY SUITE 201 NEW YORK NY 10012
Business Address 632 BROADWAY SUITE 201 NEW YORK NY 10012 (212) 651-8500
TWINLAB CONSOLIDATED HOLDINGS, INC. (Filer) CIK: 0001590695 (see all company filings)

IRS No.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55181 | Film No.: 18549802
SIC: 2833 Medicinal Chemicals & Botanical Products